Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huilin Tang

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Diabetes, Obesity & Metabolism|August 28, 2025
Cardiovascular and kidney outcomes of GLP-1 receptor agonists in adults with obesity: A target trial emulation studyHuilin Tang, Yiwen Lu, Bingyu Zhang, et al.
Diabetes, Obesity & Metabolism|September 11, 2024
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetesJingchuan Guo, Huilin Tang, Hui Shao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2025
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulationHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
European Journal of Pediatrics|November 24, 2017
Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance dataYan Xing, Hua Zhang, Shusen Sun, et al.
Diabetes Care|March 29, 2022
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome TrialsHuilin Tang, Stephen E Kimmel, Steven M Smith, et al.
JAMA Neurology|April 7, 2025
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related DementiasHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Molecular Reproduction and Development|January 23, 2002
Generation of cloned goats (Capra hircus) from transfected foetal fibroblast cells, the effect of donor cell cycleXiangang Zou, Yuge Wang, Yong Cheng, et al.
Annals of Internal Medicine|July 15, 2024
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation StudyHuilin Tang, Ying Lu, William T Donahoo, et al.
Diabetes Research and Clinical Practice|December 12, 2025
Association of GLP-1 receptor agonist use with psychiatric outcomes in adults with type 2 diabetes: a target trial emulationHuilin Tang, Yiwen Lu, Bingyu Zhang, et al.
Diabetes Care|September 1, 2019
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. AdultsTiansheng Wang, Jeff Y Yang, John B Buse, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Diabetes, Obesity & Metabolism|August 28, 2025
Cardiovascular and kidney outcomes of GLP-1 receptor agonists in adults with obesity: A target trial emulation studyHuilin Tang, Yiwen Lu, Bingyu Zhang, et al.
Diabetes, Obesity & Metabolism|September 11, 2024
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetesJingchuan Guo, Huilin Tang, Hui Shao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2025
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulationHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
European Journal of Pediatrics|November 24, 2017
Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance dataYan Xing, Hua Zhang, Shusen Sun, et al.
Diabetes Care|March 29, 2022
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome TrialsHuilin Tang, Stephen E Kimmel, Steven M Smith, et al.
JAMA Neurology|April 7, 2025
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related DementiasHuilin Tang, William T Donahoo, Steven T DeKosky, et al.
Molecular Reproduction and Development|January 23, 2002
Generation of cloned goats (Capra hircus) from transfected foetal fibroblast cells, the effect of donor cell cycleXiangang Zou, Yuge Wang, Yong Cheng, et al.
Annals of Internal Medicine|July 15, 2024
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation StudyHuilin Tang, Ying Lu, William T Donahoo, et al.
Diabetes Research and Clinical Practice|December 12, 2025
Association of GLP-1 receptor agonist use with psychiatric outcomes in adults with type 2 diabetes: a target trial emulationHuilin Tang, Yiwen Lu, Bingyu Zhang, et al.
Diabetes Care|September 1, 2019
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. AdultsTiansheng Wang, Jeff Y Yang, John B Buse, et al.
Pageof 12